2018 6-month group forecast
Aug 6 (Reuters) -
Aska Pharmaceutical Co Ltd
CONSOLIDATED EARNINGS ESTIMATES
(in billions of yen unless specified)
6 Months to 6 Months to
Sep 30, 2018 Sep 30, 2018
LATEST PREVIOUS
FORECAST FORECAST
Sales 24.00 24.00
Operating 1.10 200 mln
Recurring 1.20 300 mln
Net 800 mln 200 mln
EPS 28.38 yen 7.09 yen
NOTE - Aska Pharmaceutical Co Ltd.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4514.T
Recent news on ASKA Pharmaceutical Holdings
See all newsTable: Aska Pharmaceutical Holdings -Q1 group results
Brief: Dalton Investment Strongly Oppose Conditional Activation Of Countermeasures Announced By Aska Pharmaceutical Holdings On May 25
Brief: Aska Pharmaceutical -Plan To Put To Shareholders Proposal On Countermeasures Against Potential Large-Scale Share Purchase By Dalton And Related Parties
Table: Aska Pharmaceutical Holdings -2025/26 group results
Table: Aska Pharmaceutical Holdings -2025/26 group results